VARIABLES INFLUENCING SUSCEPTIBILITY TESTING OF CRYPTOCOCCUS-NEOFORMANS TO 5-FLUOROCYTOSINE

被引:52
作者
BLOCK, ER
JENNINGS, AE
BENNETT, JE
机构
[1] NIAID,LAB CLIN INVEST,BETHESDA,MD 20014
[2] NIH,CLIN CTR,DEPT CLIN PATHOL,BETHESDA,MD 20014
关键词
D O I
10.1128/AAC.4.4.392
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
引用
收藏
页码:392 / 395
页数:4
相关论文
共 11 条
[1]  
BLOCK ER, 1973, ANTIMICROB AGENTS CH, V8, P649
[2]  
GRUNBERG E, 1963, ANTIMICROB AGENTS CH, P566
[3]  
MARKS MI, 1970, ANTIMICROB AGENTS CH, P491
[4]   IN-VITRO STUDIES OF 5-FLUOROCYTOSINE RESISTANCE IN CANDIDA-ALBICANS AND TORULOPSIS-GLABRATA [J].
NORMARK, S ;
SCHONEBECK, J .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1972, 2 (03) :114-+
[5]   IN-VITRO ACTIVITY OF 5-FLUOROCYTOSINE AGAINST CANDIDA AND TORULOPSIS SPECIES [J].
SHADOMY, S ;
KIRCHOFF, CB ;
INGROFF, AE .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1973, 3 (01) :9-14
[6]  
SHADOMY S, 1970, Infection and Immunity, V2, P484
[7]   IN VITRO STUDIES WITH 5-FLUOROCYTOSINE [J].
SHADOMY, S .
APPLIED MICROBIOLOGY, 1969, 17 (06) :871-&
[8]  
SHADOMY S, 1968, ANTIMICROB AGENTS CH, P452
[9]   5-FLUOROCYTOSINE - ORAL ANTIFUNGAL COMPOUND - REPORT ON CLINICAL AND LABORATORY EXPERIENCE [J].
STEER, PL ;
MARKS, MI ;
KLITE, PD ;
EICKHOFF, TC .
ANNALS OF INTERNAL MEDICINE, 1972, 76 (01) :15-+
[10]   CANDIDA AT BOSTON-CITY-HOSPITAL - CLINICAL AND EPIDEMIOLOGICAL CHARACTERISTICS AND SUSCEPTIBILITY TO 8 ANTIMICROBIAL AGENTS [J].
TOALA, P ;
SCHROEDER, SA ;
DALY, AK ;
FINLAND, M .
ARCHIVES OF INTERNAL MEDICINE, 1970, 126 (06) :983-+